Cost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment
Journal Title: Electronic Physician - Year 2016, Vol 8, Issue 12
Abstract
INTRODUCTION: Fractures caused by osteoporosis are prevalent among elderly females, which reduce quality of life significantly. This study aimed at comparing cost-effectiveness of Zoledronic acid in preventing and treating post-menopause osteoporosis as compared with routine medical treatment. METHODS: This cost-effectiveness study was carried out retrospectively from the Ministry of Health and insurance organizations perspective. Costs were evaluated based on the cost estimation of a sample of patients. Outcomes were obtained from a systematic review. The Cost-Effectiveness Ratio (CER) and incremental cost-effectiveness ratio (ICER) for outcome of femoral neck Bone Mineral Density (BMD), hip trochanter BMD, total hip BMD and lumbar spine BMD and cost-benefit of consuming Zoledronic Acid were calculated for fracture outcome obtained from reviewing hospital records. RESULTS: The results and the ICER calculated for study outcomes indicated that one percent increase of BMD on femoral neck BMD requires further cost of $386. One percent increase of BMD on hip trochanter BMD requires further cost of $264. One percent increase of BMD on total hip BMD requires further cost of $388, one percent increase of BMD on lumbar spine BMD requires further cost of $347. The Cost Benefit Analysis (CBA) calculated for vertebral and hip fracture, non-vertebral fracture, any clinical fracture, and morphometric fracture for a 36-month period were about 0.82, 0.57, and 1.06, respectively. Vertebral and hip fractures, and non-vertebral fractures or any clinical fracture for a 12-month period were calculated as 1.14 and 0.64, respectively. In other words, Zoledronic acid consumption approach is a cheaper and better approach based on an economic assessment, and it can be considered as a dominant approach. CONCLUSION: According to the cost-effectiveness of zoledronic acid in the prevention and treatment of osteoporosis in women, despite the costs, it is recommended that insurance coverage for the drug should be considered in the period after menopause and the benefits of this drug. This can reduce the costs imposed on the patients and also it can reduce the economic burden on the community, particularly as a result of the fracture
Authors and Affiliations
Golmohamdi FR, Abbasi M, Karyani AK, Sari AA
Keywords
Related Articles
- EP ID EP339559
- DOI 10.19082/3434
- Views 88
- Downloads 0
Psychometric properties of self-assessment clinical competency questionnaire in baccalaureate nursing students
BACKGROUND: One of the main challenges of nursing student education is the lack of clinical competence that reduces the quality of patients care. Measuring the clinical competency of undergraduate nursing students is eff...
The story of fake impact factor companies and how we detected them.
Beginning about three years ago, the world of academic publishing has become infected by fake impact factors and misleading metrics that are launched by bogus companies. The misleading metrics and fake impact factors hav...
Serum level of vitamin D in preterm infants and its association with premature-related respiratory complications: a case-control study
BACKGROUND AND AIM: Prematurity and related problems, especially respiratory distress, are one of the main challenges for neonatal medicine. The aim of this study was to compare vitamin D levels in preterm infants with,...
New corruption detected: Bogus impact factors compiled by fake organizations
Study on attitudes of students of Islamic Azad University Tehran Medical Branch toward food safety, 2016
BACKGROUND: Given the importance of high-quality healthy food for humans, contamination control is the most important concern for healthy staff. AIM: To determine the attitudes of students at Islamic Azad University (Te...